◆ 会议时间：2023年2月15-19日
◆ 会议地点：中国 台湾-台北

◆ 会议简介：

2023年第32届亚太肝脏研究协会(APASL)年会将于2023年2月15-19日在中国台湾台北举行，会议由亚太肝脏研究协会(APASL)、韩国肝脏研究协会(KASL)联合组织。APASL年会(亚太肝病年会)是亚太地区肝病学领域最具影响力的学术会议，大会科学计划涵盖肝脏学的所有方面，是与会者分享经验、知识和造福亚太地区人民的重要平台。大会组委会正在制定一项全面而又令人兴奋的科学计划，以反映当前最先进的技术和最具争议性的问题；众多世界知名的演讲者和代表将分享他们的专业知识、卓越成就和创新理念。

亚太肝脏研究协会（APASL）成立于1978年，是全球领先的致力于肝病研究和治疗的协会之一，是奉行标准与专业，为亚太地区数百万肝病患者研究和改进治疗方法的最大科学机构。APASL的主要目标是推动肝病学的最新科学发展与教育，交流信息和发展共识，鼓励肝脏病学的医学实践，协调区域内科学家和临床医生之间的科学研究；APASL定期召开科学教育研讨会/会议，由专家讲者宣通过高质量的科学技术报告呈现肝脏疾病热点话题中的最新数据，为参与者提供一个交流研究、讨论成果和与同事互动的平台。

APASL年会将为与会者提供高质量的科学教育内容，由一流的研究人员和临床医生报告涵盖肝病各个方面的最新信息宣。会议将为各机构、学术单位、企业、协会、非营利组织和其他相关部门提供一个交流与合作的途径，是为所有人分享我们在肝病方面的观点、价值观、经验和做法的最佳机会，如病毒性肝炎，肝癌，非酒精性脂肪性肝炎(NASH)，肝衰竭，门静脉高压症，酒精性肝病，肝移植，小儿肝病、肝脏放射学以及其它主题等。未经许可禁止复制摘录转载本站任何内容-国际医学会议网（lingyuint.com）.

The 32nd Conference of the Asian Pacific Association for the Study of the Liver-APASL 2023

会议时间/Date:
February 15-19, 2023

会议地点/Venue:
Taipei International Convention Center, Taipei, Taiwan, China

大会主题/Theme：
Innovation and Paradigm Shift in Hepatology

大会官方语言/Official Language：
English

主办单位/Hosted & Organized by：
Asian Pacific Association for the Study of the Liver (APASL)
Taiwan Association for the Study of the Liver (TASL)
Taiwan Association for the Study of the Liver Foundation (TASLF)

摘要提交/CALL FOR ABSTRACTS：
Abstract Submission Open: May 2, 2022
Abstract Submission Deadline: October 31, 2022
Notification of Abstract Acceptance: TBA
Registration Deadline for Presenting Author： November 15, 2022

点此提交摘要>>>Submit Abstract>>>

Dear colleagues, ladies and gentlemen,

On behalf of the organizing committee, it is my great pleasure to invite you to join the 2023 annual meeting of the Asian Pacific Association for the Study of the Liver (APASL), which will be held at the Taipei International Convention Center in Taiwan on February 15 – 19, 2023.

The theme of APASL 2023 is “Innovation and Paradigm Shift in Hepatology”. Over the past decades, our cumulative knowledge has made dramatic progress in the field of hepatology, changing various treatment concepts in liver diseases. Such progress includes the use of direct anti-viral agents in the treatment of hepatitis C, various systemic therapeutic agents in the treatment of hepatocellular carcinoma, the use of artificial intelligence to support the diagnosis of liver diseases, etc. To build on our collective commitment in making continuing progress in this field, APASL is organizing a comprehensive scientific program including state-of-the-art lectures, symposiums, and workshops, etc. Our goal is to bring together renowned investigators from all over the world to share their latest research findings and knowledge on current hepatology.

As you all know, the COVID-19 pandemic has created a significant impact on how conferences are held. Due to the continued uncertainty of the pandemic and related travel restrictions, APASL 2023 will be held in a hybrid format. For those who may not be able to attend in person, the hybrid format of the conference provides an online forum for all of us to continue our fruitful discussion of the various scientific programs. For those who can attend in person, I hope you will also enjoy the beautiful landscape and delicious local cuisines that the host city of Taipei offers.

The organizing committee believes that APASL 2023 will bring you the most comprehensive knowledge in both fundamental and clinical science in the field of hepatology.

I look forward to meeting all of you at APASL 2023.

Sincerely yours,

Han-Chieh Lin
President
APASL 2023 Annual Meeting

APASL2023 注册费 - REGISTRATION FEE:

Deadline of Presenting Author Registration 23:59, January 2, 2023

◆ 参会对象：医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。